Phio Pharmaceuticals Corp.
(NASDAQ : PHIO)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
TSROTESARO, Inc.
0.37%73.9314.4%$593.48m
AMGNAmgen Inc.
-0.12%189.861.2%$550.65m
GILDGilead Sciences, Inc.
1.71%66.230.9%$544.57m
CELGCelgene Corporation
-0.48%67.801.2%$491.55m
ILMNIllumina, Inc.
0.81%313.423.5%$342.30m
BIIBBiogen Inc.
-4.39%299.361.3%$340.11m
REGNRegeneron Pharmaceuticals, Inc.
0.15%376.062.6%$269.48m
AAgilent Technologies, Inc.
0.84%68.421.5%$216.34m
VRTXVertex Pharmaceuticals Incorporated
1.16%168.091.9%$215.85m
ALXNAlexion Pharmaceuticals, Inc.
0.03%109.562.0%$153.87m
INCYIncyte Corporation
0.83%65.362.5%$97.98m
EXASExact Sciences Corporation
-0.33%66.8925.3%$93.40m
BLUEBluebird Bio, Inc.
-2.04%102.4414.4%$85.74m
SRPTSarepta Therapeutics, Inc.
-1.86%113.5515.4%$82.89m
GBTGlobal Blood Therapeutics Inc
0.60%41.827.0%$81.33m

Company Profile

Phio Pharmaceuticals Corp. is a biotechnology company, which engages in developing therapeutics that address unmet medical needs. Its clinical product candidate includes RXI-109, a RNAi compound developed for the reduction of dermal scarring in planned surgeries. The company was founded on September 8, 2011 and is headquartered in Marlborough, MA.